{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:56:21Z","timestamp":1791608181197,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.ajo.2008.06.016","type":"journal-article","created":{"date-parts":[[2008,9,7]],"date-time":"2008-09-07T13:31:31Z","timestamp":1220794291000},"page":"700-706.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Intravenous Thrombolysis With Low-dose Recombinant Tissue Plasminogen Activator in Central Retinal Artery Occlusion"],"prefix":"10.1016","volume":"146","author":[{"given":"Lars-Olof","family":"Hattenbach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Kuhli-Hattenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Scharrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Baatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2008.06.016_bib1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1160\/TH05-03-0684","article-title":"Treatment of acute central retinal artery occlusion with the platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban","volume":"94","author":"H\u00f6lschermann","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajo.2008.06.016_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0002-9394(99)00359-1","article-title":"Aggressive systematic treatment for central retinal artery occlusion","volume":"128","author":"Rumelt","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/archopht.121.10.1377","article-title":"Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion","volume":"121","author":"Mueller","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0002-9394(03)00817-1","article-title":"Neodymium:yttrium-aluminum-garnet laser arteriotomy with embolectomy for central retinal artery occlusion","volume":"137","author":"Reynard","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/bjo.2006.097642","article-title":"Surgical embolus removal in retinal artery occlusion","volume":"90","author":"Garcia-Arumi","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0002-9394(88)90008-6","article-title":"Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi","volume":"105","author":"Vine","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(14)76167-7","article-title":"Microcatheter urokinase infusion in central retinal artery occlusion","volume":"113","author":"Schmidt","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib8","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/BF00588405","article-title":"Intraarterial fibrinolytic therapy in central retinal artery occlusion","volume":"35","author":"Schumacher","year":"1993","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ajo.2008.06.016_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0161-6420(99)90165-3","article-title":"Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator","volume":"106","author":"Richard","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2008.06.016_bib10","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bjo.84.8.914","article-title":"Local intra-arterial fibrinolysis for acute occlusion of the central retinal artery: a meta-analysis of the published data","volume":"84","author":"Beatty","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib11","first-page":"1301","article-title":"Prognosis of central retinal artery occlusion: local intra-arterial fibrinolysis versus conservative treatment","volume":"23","author":"Schmidt","year":"2002","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.ajo.2008.06.016_bib12","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/02841850312331287829","article-title":"Selective intraarterial fibrinolysis of acute central retinal artery occlusion","volume":"44","author":"Butz","year":"2003","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ajo.2008.06.016_bib13","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1136\/jnnp.2004.037135","article-title":"Comparison of intra-arterial thrombolysis with conventional treatment in patients with acute central retinal artery occlusion","volume":"76","author":"Arnold","year":"2005","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.ajo.2008.06.016_bib14","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00417-005-0140-2","article-title":"Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications","volume":"244","author":"Feltgen","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib15","first-page":"1234","article-title":"Intravenous recombinant tissue-type plasminogen activator thrombolysis in treatment of central retinal artery occlusion","volume":"120","author":"Kattah","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib16","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1055\/s-2005-866777","article-title":"Systemic fibrinolytic therapy using urokinase in central retinal artery occlusion","volume":"130","author":"von Mach","year":"2005","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.ajo.2008.06.016_bib17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1055\/s-2008-1045968","article-title":"Thrombolytic treatment of retinal arterial occlusions with plasminogen activator [in German]","volume":"198","author":"Bertram","year":"1991","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.ajo.2008.06.016_bib18","doi-asserted-by":"crossref","first-page":"A21","DOI":"10.1016\/0002-9149(92)91169-5","article-title":"Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis","volume":"69","author":"Sloan","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajo.2008.06.016_bib19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9149(91)90738-7","article-title":"Older age and elevated blood pressure are risk factors for intracerebral hemorrhage after thrombolysis","volume":"68","author":"Anderson","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajo.2008.06.016_bib20","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0014-4835(03)00214-8","article-title":"Central retinal artery occlusion","volume":"78","author":"Hayreh","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ajo.2008.06.016_bib21","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/bjo.64.12.913","article-title":"Visual prognosis following treatment of acute central retinal artery obstruction","volume":"64","author":"Augsburger","year":"1980","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0002-9394(14)72731-X","article-title":"Retinal arterial occlusions in young adults","volume":"120","author":"Greven","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib23","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1136\/hrt.2004.041814","article-title":"Calcific retinal embolism as an indicator of severe unrecognised cardiovascular disease","volume":"91","author":"Ramakrishna","year":"2005","journal-title":"Heart"},{"key":"10.1016\/j.ajo.2008.06.016_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/WNO.0b013e31814b1f66","article-title":"Thrombolysis for central retinal artery occlusion","volume":"27","author":"Biousse","year":"2007","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/01.STR.0000202582.29510.6b","article-title":"Therapy of basilar artery occlusion: a systematic analysis comparing intra-arterial and intravenous thrombolysis","volume":"37","author":"Lindsberg","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.ajo.2008.06.016_bib26","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/jama.1995.03530130023023","article-title":"Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke","volume":"274","author":"Hacke","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ajo.2008.06.016_bib27","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1552-6569.2007.00121.x","article-title":"Intra-arterial thrombolysis for central retinal artery occlusion in the United States: Nationwide In-patient Survey 2001\u20132003","volume":"17","author":"Suri","year":"2007","journal-title":"J Neuroimaging"},{"key":"10.1016\/j.ajo.2008.06.016_bib28","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1378\/chest.126.3_suppl.549S","article-title":"Thrombolysis and adjunctive therapy in acute myocardial infarction: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Menon","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ajo.2008.06.016_bib29","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1161\/01.STR.23.5.632","article-title":"Urgent therapy for stroke","volume":"23","author":"Brott","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.ajo.2008.06.016_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/01.STR.23.5.641","article-title":"Urgent therapy for stroke","volume":"23","author":"Haley","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.ajo.2008.06.016_bib31","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1056\/NEJM199309023291001","article-title":"An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2008.06.016_bib32","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1056\/NEJM199311253292204","article-title":"The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2008.06.016_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1159\/000027374","article-title":"Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion","volume":"212","author":"Hattenbach","year":"1998","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajo.2008.06.016_bib34","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ajo.2005.04.020","article-title":"Transient monocular visual loss","volume":"140","author":"Biousse","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2008.06.016_bib35","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","article-title":"Tissue plasminogen activator for acute ischemic stroke","volume":"333","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2008.06.016_bib36","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJM199906103402302","article-title":"Effects of tissue plasminogen activator for acute ischemic stroke at one year","volume":"340","author":"Kwiatkowski","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2008.06.016_bib37","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1001\/jama.279.16.1265","article-title":"Low molecular weight heparinoid, Org 10172 (danaparoid), and outcome after acute ischemic stroke","volume":"279","year":"1998","journal-title":"JAMA"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408004820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939408004820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:56:43Z","timestamp":1757595403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939408004820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0002939408004820"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2008.06.016","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous Thrombolysis With Low-dose Recombinant Tissue Plasminogen Activator in Central Retinal Artery Occlusion","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2008.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2008.07.025","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}